HR0129LRB104 12087 MST 22185 r

1
HOUSE RESOLUTION

 
2    WHEREAS, Vaccination is proven to be a safe, invaluable
3tool to proactively safeguard public health and prevent the
4devastating effects of vaccine-preventable diseases; and
 
5    WHEREAS, Vaccination has averted over 154 million deaths
6globally since 1974, of which 146 million were among children
7younger than five years of age; and
 
8    WHEREAS, Vaccination has greatly reduced morbidity and
9mortality by eradicating vaccine-preventable diseases (e.g.,
10smallpox) and has greatly reduced the incidence of infections
11such as meningitis, measles, polio, and rubella; and
 
12    WHEREAS, Timely meningococcal vaccination in children and
13young adults helps protect against the debilitating effects of
14meningococcal disease, including death, and has led to a
15significant decrease in incidence; and
 
16    WHEREAS, Vaccination for highly contagious diseases such
17as measles is incredibly important; in order to achieve herd
18immunity against measles, 95% of the population must be
19vaccinated; if measles vaccination coverage rates drop below
20that threshold, outbreaks and preventable deaths will
21ultimately occur; therefore, maintaining high vaccine coverage

 

 

HR0129- 2 -LRB104 12087 MST 22185 r

1rates is critical to protect the public and prevent
2transmission; and
 
3    WHEREAS, An analysis of costs associated with invasive
4meningococcal disease outbreaks found that the average cost
5per outbreak containment strategy was almost $440,000
6($299,641 and $579,851 for small and large containment
7strategies, respectively); and
 
8    WHEREAS, Among the approximately 117 million children born
9during 1994-2023 in the United States, vaccination averted 508
10million lifetime cases of illness, 32 million
11hospitalizations, and 1.1 million deaths, resulting in
12estimated savings of $540 billion in direct medical costs and
13$2.7 trillion in societal costs; and
 
14    WHEREAS, Vaccination can prevent the development of
15cancers later in life (e.g., human papillomavirus vaccination,
16which has contributed to a 65% reduction in cervical cancer
17incidence over the last decade); and
 
18    WHEREAS, Vaccination for four common diseases in older
19adults, including shingles, is estimated to prevent 64 million
20cases and $185 billion in treatment costs over the next 30
21years in the United States; and
 

 

 

HR0129- 3 -LRB104 12087 MST 22185 r

1    WHEREAS, While vaccinating children provides substantial
2health and economic benefit, vaccinating adults is also
3important; many childhood vaccines provide life-long
4protection; however, immunity can decrease over a person's
5lifetime, and some vaccine-preventable diseases can be more
6severe in adults; and
 
7    WHEREAS, There continues to be disease burden in adults,
8especially in those with comorbidities, advanced age, or
9immunocompromising conditions, warranting continued, timely
10vaccination, especially against viruses that change frequently
11(e.g., influenza, COVID-19); and
 
12    WHEREAS, For example, vaccination against shingles for
13high-risk adults aged 19 and older, as well as all adults aged
1450 and older, has proven highly effective in preventing both
15the infection and its transmission, offering long-lasting
16protection for several years after immunization; and
 
17    WHEREAS, For example, respiratory syncytial virus
18vaccination in older adults is an effective preventive measure
19that reduces the likelihood of hospitalization and critical
20illness due to respiratory syncytial virus infection; and
 
21    WHEREAS, Vaccines remain a safe and effective public
22health measure; in the United States, vaccines undergo a

 

 

HR0129- 4 -LRB104 12087 MST 22185 r

1thorough regulatory review process, which includes Food and
2Drug Administration (FDA) approval and a recommendation from
3the Advisory Committee on Immunization Practices (ACIP) after
4careful evaluation; therefore, be it
 
5    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE
6HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that
7we declare April 10, 2025 as Vaccine Awareness Day in the State
8of Illinois to educate the public about the importance of
9vaccinations, initiate meaningful dialogue around
10vaccinations, and encourage the uptake of vaccines; and be it
11further
 
12    RESOLVED, That we urge the Illinois Department of Health
13to continue to promote to healthcare providers and the people
14of this state that vaccinations are a highly effective and
15safe public health measure and increase public awareness about
16the importance of all Illinois residents receiving recommended
17immunizations, and to promote outreach and education efforts
18concerning vaccinations; and be it further
 
19    RESOLVED, That we urge the Illinois Department of Health
20to continue to prioritize immunization initiatives, develop
21policies, and invest in immunization infrastructure to ensure
22broad and open access to immunizations to safeguard public
23health and protect the well-being of Illinois residents.